george calin
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
- Frontiers in Oncology
- Cancer Molecular Targets and Therapeutics
- Editorial Board
Type at least 3 characters
669 editors
Shape the future of research in your field
Join the board
Editors
Associate Editors
fabrizio carta
University of Florence
Florence, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
giuliana cassinelli
National Cancer Institute Foundation (IRCCS)
Milan, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
carlo catapano
Institute of Oncology Research (IOR)
Bellinzona, Switzerland
Associate Editor
Cancer Molecular Targets and Therapeutics
ferdinando cerciello
Department of Medical Oncology, Bern University Hospital
Bern, Switzerland
Associate Editor
Cancer Molecular Targets and Therapeutics
sanjukta chakraborty
Texas A and M University
College Station, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
hai lan chen
Old Dominion University
Norfolk, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
suzie chen
Rutgers, The State University of New Jersey
New Brunswick, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
chun hei antonio cheung
College of Medicine, National Cheng Kung University
Tainan, Taiwan
Associate Editor
Cancer Molecular Targets and Therapeutics
peter m chumakov
Engelhardt Institute of Molecular Biology (RAS)
Moscow, Russia
Associate Editor
Cancer Molecular Targets and Therapeutics
bekir cinar, ph.d.
Clark Atlanta University
Atlanta, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
maria rosa ciriolo
University of Rome Tor Vergata
Roma, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
francois x. claret
University of Texas MD Anderson Cancer Center
Houston, United States
Associate Editor
Cancer Molecular Targets and Therapeutics
olivia crociani
University of Florence
Florence, Italy
Associate Editor
Cancer Molecular Targets and Therapeutics
gabi u dachs
University of Otago, Christchurch
Christchurch, New Zealand
Associate Editor
Cancer Molecular Targets and Therapeutics
yun dai
First Affiliated Hospital of Jilin University
Changchun, China
Associate Editor
Cancer Molecular Targets and Therapeutics